| |
| |
|
| Insider
Information: |
Crowley John F |
| Relationship: |
Director |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
590,194 |
|
|
Indirect Shares
|
97,759 |
|
|
| Direct
Value |
$6,353,484 |
|
|
|
Indirect Value
|
$688,536 |
|
|
| Total
Shares |
687,953 |
|
|
| Total
Value |
$7,042,020 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
298 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2008-09-03 |
4 |
AS |
$13.75 |
$34,411 |
I/I |
(2,500) |
17,700 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2008-09-04 |
4 |
AS |
$13.83 |
$34,599 |
I/I |
(2,500) |
16,400 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President and CEO |
• • – |
2008-09-05 |
4 |
AS |
$13.74 |
$34,356 |
I/I |
(2,500) |
15,200 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2008-10-01 |
4 |
AS |
$15.08 |
$21,113 |
I/I |
(1,400) |
14,600 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2008-10-02 |
4 |
AS |
$15.06 |
$39,251 |
I/I |
(2,600) |
13,300 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2008-10-03 |
4 |
AS |
$14.96 |
$55,381 |
I/I |
(3,700) |
11,400 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2008-10-06 |
4 |
AS |
$14.75 |
$33,937 |
I/I |
(2,300) |
10,200 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2008-11-03 |
4 |
AS |
$10.27 |
$102,785 |
I/I |
(10,000) |
5,200 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2009-07-14 |
4 |
AS |
$10.28 |
$48,819 |
D/D |
(4,748) |
79,736 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2009-07-15 |
4 |
AS |
$10.69 |
$69,472 |
D/D |
(6,500) |
73,236 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
President & CEO |
• • – |
2009-07-16 |
4 |
AS |
$10.29 |
$36,001 |
D/D |
(3,500) |
69,736 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2014-12-04 |
4 |
AS |
$8.36 |
$743,907 |
D/D |
(89,000) |
109,083 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-03-20 |
4 |
AS |
$11.49 |
$3,082,242 |
D/D |
(268,322) |
83,499 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-04-10 |
4 |
AS |
$12.00 |
$140,136 |
D/D |
(11,678) |
83,499 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-06-08 |
4 |
AS |
$13.01 |
$715,550 |
D/D |
(55,000) |
83,499 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-07-13 |
4 |
AS |
$15.01 |
$116,315 |
D/D |
(7,750) |
83,499 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-07-14 |
4 |
AS |
$15.03 |
$2,137,676 |
D/D |
(142,250) |
83,499 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2015-07-16 |
4 |
AS |
$16.00 |
$256,400 |
D/D |
(16,025) |
83,499 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-12 |
4 |
AS |
$14.25 |
$5,414,810 |
D/D |
(380,000) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-13 |
4 |
AS |
$14.75 |
$326,867 |
D/D |
(22,160) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-16 |
4 |
AS |
$14.75 |
$695,241 |
D/D |
(47,135) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-17 |
4 |
AS |
$14.75 |
$777,650 |
D/D |
(52,722) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-10-18 |
4 |
AS |
$14.76 |
$280,544 |
D/D |
(19,013) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-12-04 |
4 |
AS |
$13.61 |
$642,734 |
D/D |
(47,213) |
328,001 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Chairman & CEO |
• • – |
2017-12-11 |
4 |
AS |
$13.52 |
$164,973 |
D/D |
(12,206) |
328,001 |
0 |
- |
|
298 Records found
|
|
Page 3 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
